In the context of public health crises, clinical trials and health technology assessment (HTA) can contribute to speeding up the development and identification of effective medical countermeasures. It should therefore be possible for the Programme to provide support to facilitate actions in those fields.
Recital 13, Regulation (EU) 2021/522
In forcesince 24 Mar 2021